ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
DRK
Sphere 3D Corp.
There isn't enough reported data to score DRK yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DRK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
DRK's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
DRK PE Valuation
DRK has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
DRK Forward outlook
There aren't enough analyst estimates for DRK to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
DRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.78 | -$0.53 |
| Q2 2026 | -$8.63 | -$2.93 |
| Q1 2026 | -$5.35 | -$0.05 |
| Q4 2025 | -$7.37 | -$2.57 |
| Q3 2025 | -$7.25 | +$3.80 |
| Q2 2025 | -$5.70 | +$10.40 |
| Q1 2025 | -$5.30 | +$16.20 |
| Q4 2024 | -$4.80 | +$17.50 |
DRK has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over DRK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
DRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3M | +16% |
| Q2 2026 | $2.5M | -19% |
| Q1 2026 | $1.9M | -32% |
| Q4 2025 | $2.7M | +3.1% |
| Q3 2025 | $2.6M | +11% |
| Q2 2025 | $3M | -35% |
| Q1 2025 | $2.8M | -59% |
| Q4 2024 | $2.6M | -66% |
DRK's revenue is recovering but still below its 2023 peak: $3M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -191% | -37 points |
| Q2 2026 | -564% | -477 points |
| Q1 2026 | -216% | -31 points |
| Q4 2025 | -373% | -44 points |
| Q3 2025 | -154% | +65 points |
| Q2 2025 | -87% | +35 points |
| Q1 2025 | -184% | -157 points |
| Q4 2024 | -329% | -132 points |
DRK has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
DRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.5M | +$1.3M |
| Q2 2026 | -$5.3M | +$745K |
| Q1 2026 | -$3.7M | +$1.4M |
| Q4 2025 | -$6.7M | -$904K |
| Q3 2025 | -$5.7M | -$1.4M |
| Q2 2025 | -$6.1M | -$2.8M |
| Q1 2025 | -$5.1M | -$5M |
| Q4 2024 | -$5.8M | -$5.3M |
DRK has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over DRK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
DRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +71% | +3.7M shares |
| 1 year | +219% | +6.1M shares |
| 3 years | +8805% | +8.7M shares |
DRK has 9M diluted shares, up 219% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DRK Net Leverage
DRK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
DRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 5.2 | Oversold |
DRK's weekly RSI is 42 (neutral) and its Stochastic is 5 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
DRK PE vs Technology Sector
DRK has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over DRK on trend strength, trading above more of its moving averages.
DRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.18 | 24% below |
| 20 week MA | $2.26 | 27% below |
| 50 week MA | $2.34 | 29% below |
| 100 week MA | $4.61 | 64% below |
| 200 week MA | $10.8 | 85% below |
DRK is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over DRK on returns for 2026, with the stronger performance.
DRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.2 | $109.2 | +113% |
| 2021 | $109.2 | $247.8 | +127% |
| 2022 | $247.8 | $21.0 | -92% |
| 2023 | $21.0 | $33.2 | +58% |
| 2024 | $33.2 | $9.61 | -71% |
| 2025 | $9.61 | $3.61 | -62% |
| 2026 YTD | $3.61 | $1.66 | -54% |
DRK's yearly returns have swung widely, from +127% in 2021 to −92% in 2022. It's down 54% so far in 2026.